We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+2.41%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$8.93B
AUM Growth
+$814M
Cap. Flow
+$728M
Cap. Flow %
8.15%
Top 10 Hldgs %
12.09%
Holding
2,052
New
174
Increased
1,355
Reduced
425
Closed
84

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$24.5M
2
IBM icon
IBM
IBM
+$18M
3
AAPL icon
Apple
AAPL
+$15.5M
4
SNY icon
Sanofi
SNY
+$13.7M
5
AGN
Allergan plc
AGN
+$13.6M

Sector Composition

Rank Sector Weight
1 Financials 17.05%
2 Healthcare 15.22%
3 Technology 14.48%
4 Industrials 8.72%
5 Consumer Staples 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEO icon
1126
American Eagle Outfitters
AEO
$2.88B
$656K 0.01%
38,414
+385
+1% +$5.87K
NPK icon
1127
National Presto Industries
NPK
$870M
$656K 0.01%
+10,344
New +$638K
SAM icon
1128
Boston Beer
SAM
$1.91B
$656K 0.01%
2,455
+1,197
+95% +$347K
AEL
1129
DELISTED
American Equity Investment Life Holding Company
AEL
$655K 0.01%
22,473
+17
+0.1% +$477
DNB
1130
DELISTED
Dun & Bradstreet
DNB
$654K 0.01%
5,097
+32
+0.6% +$4.01K
AAV
1131
DELISTED
Advantage Oil & Gas Ltd
AAV
$654K 0.01%
122,098
-4,236
-3% -$20.6K
HAE icon
1132
Haemonetics
HAE
$3.89B
$651K 0.01%
14,484
+1,244
+9% +$52K
KRC icon
1133
Kilroy Realty
KRC
$4.52B
$651K 0.01%
8,550
+809
+10% +$60.3K
WCC
1134
WESCO International
WCC
$16.7B
$649K 0.01%
9,284
-2,642
-22% -$183K
TRMB icon
1135
Trimble
TRMB
$13.2B
$648K 0.01%
25,726
+1,476
+6% +$37.9K
KND
1136
DELISTED
Kindred Healthcare
KND
$648K 0.01%
27,221
+8,712
+47% +$177K
CLB icon
1137
Core Laboratories
CLB
$490M
$647K 0.01%
6,195
-314
-5% -$33.5K
ENOV icon
1138
Enovis
ENOV
$1.68B
$645K 0.01%
7,852
+4,347
+124% +$364K
PPC icon
1139
Pilgrim's Pride
PPC
$6.51B
$645K 0.01%
+28,536
New +$811K
UNT
1140
DELISTED
UNIT Corporation
UNT
$645K 0.01%
23,047
+28
+0.1% +$833
TDY icon
1141
Teledyne Technologies
TDY
$30.4B
$644K 0.01%
6,030
-442
-7% -$44.3K
CLDX icon
1142
Celldex Therapeutics
CLDX
$2.99B
$640K 0.01%
1,532
-16
-1% -$5.72K
CACI icon
1143
CACI
CACI
$11B
$639K 0.01%
7,110
+611
+9% +$53.4K
SNX icon
1144
TD Synnex
SNX
$20.4B
$637K 0.01%
16,484
+1,528
+10% +$58.7K
LTRPA
1145
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$637K 0.01%
20,045
+3,673
+22% +$106K
SKYW icon
1146
Skywest
SKYW
$4.24B
$636K 0.01%
43,561
+6,393
+17% +$88.9K
PRXL
1147
DELISTED
Parexel International Corp
PRXL
$635K 0.01%
9,198
-64
-0.7% -$4.08K
CNL
1148
DELISTED
CLECO CRP (HOLDING CO)
CNL
$635K 0.01%
11,648
+645
+6% +$35.1K
SSRI
1149
DELISTED
Silver Standard Resources
SSRI
$634K 0.01%
139,940
+129,551
+1,247% +$720K
BMR
1150
DELISTED
BIOMED REALTY TRUST INC
BMR
$633K 0.01%
27,940
+403
+1% +$9.26K

Similar funds

Aperio Group's Q1 2015 Portfolio in Review

As of Q1 2015, Aperio Group held 2,052 positions worth $8.93B, up 10% from $8.11B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Aperio Group deployed $728M of net new capital in Q1 2015, opening 174 new positions and adding to 1,355 existing holdings. Its largest new stake was Paramount Group: 95,957 shares worth $1.85M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Royal Dutch Shell PLC ADS Class A, an estimated $6.37M trimmed.

  • Aperio Group's largest Q1 2015 buy was Paramount Group: 95,957 shares worth $1.85M.
  • Aperio Group added most to Starbucks in Q1 2015, an estimated $24.5M increase.
  • Aperio Group's biggest Q1 2015 reduction was Royal Dutch Shell PLC ADS Class A, cutting an estimated $6.37M.
  • Aperio Group fully exited Allergan Inc in Q1 2015, selling an estimated $20.2M.
  • Aperio Group's ten largest holdings make up 12% of its $8.93B portfolio in Q1 2015.
  • Aperio Group opened 174 new positions and closed 84 in Q1 2015.
  • Aperio Group's portfolio value rose 10% quarter-over-quarter to $8.93B.

Based on Aperio Group's 13F filing for Q1 2015, filed 29 Apr 2015.